loratadine has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serra, HA | 1 |
| Alves, O | 1 |
| Rizzo, LF | 1 |
| Devoto, FM | 1 |
| Ascierto, H | 1 |
1 trial available for loratadine and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
Loratadine-pseudoephedrine in children with allergic rhinitis, a controlled double-blind trial.
Topics: Adolescent; Anti-Allergic Agents; Argentina; Bronchodilator Agents; Child; Child, Preschool; Cross-O | 1998 |